{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:12:13Z","timestamp":1789150333840,"version":"build-2803163510"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00210-021-02196-x","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:03:51Z","timestamp":1641269031000},"page":"133-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review"],"prefix":"10.1007","volume":"395","author":[{"given":"Fatemeh","family":"Moradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"2196_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ (2013) Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437\u2013449","journal-title":"J Inherit Metab Dis"},{"key":"2196_CR2","doi-asserted-by":"publisher","unstructured":"Adamczyk-Grochala J, Lewinska A (2020) Nano-based theranostic tools for the detection and elimination of senescent cells. Cells 9. https:\/\/doi.org\/10.3390\/cells9122659","DOI":"10.3390\/cells9122659"},{"key":"2196_CR3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-510X(77)90104-6","volume":"31","author":"D Adams","year":"1977","unstructured":"Adams D, Joyce G, Richardson V, Ryman BE, Wi\u015bniewski H (1977) Liposome toxicity in the mouse central nervous system. J Neurol Sci 31:173\u2013179","journal-title":"J Neurol Sci"},{"key":"2196_CR4","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1039\/c6nr07581a","volume":"9","author":"E Ahmad","year":"2017","unstructured":"Ahmad E et al (2017) Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles. Nanoscale 9:1174\u20131183. https:\/\/doi.org\/10.1039\/c6nr07581a","journal-title":"Nanoscale"},{"key":"2196_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A et al (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:1\u20139","journal-title":"Nanoscale Res Lett"},{"key":"2196_CR6","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/IJN.S210876","volume":"14","author":"A Alexander","year":"2019","unstructured":"Alexander A et al (2019) Recent expansions of novel strategies towards the drug targeting into the brain. Int J Nanomed 14:5895","journal-title":"Int J Nanomed"},{"key":"2196_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"S Amor","year":"2010","unstructured":"Amor S, Puentes F, Baker D, Van Der Valk P (2010) Inflammation in Neurodegenerative Diseases. Immunology 129:154\u2013169","journal-title":"Immunology"},{"key":"2196_CR8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acs.molpharmaceut.8b01344","volume":"16","author":"J Aparicio-Blanco","year":"2019","unstructured":"Aparicio-Blanco J, Romero IA, Male DK, Slowing K, Garc\u00eda-Garc\u00eda L, Torres-Su\u00e1rez AI (2019) Cannabidiol enhances the passage of lipid nanocapsules across the blood\u2013brain barrier both in vitro and in vivo. Mol Pharm 16:1999\u20132010","journal-title":"Mol Pharm"},{"key":"2196_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.15171\/bi.2016.30","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar J, Rafi MA, Pourseif MM, Omidi Y (2016) Blood-brain barrier transport machineries and targeted therapy of brain diseases. Bioimpacts 6:225\u2013248. https:\/\/doi.org\/10.15171\/bi.2016.30","journal-title":"Bioimpacts"},{"key":"2196_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425247.2018.1429401","volume":"15","author":"L Battaglia","year":"2018","unstructured":"Battaglia L et al (2018) Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opin Drug Deliv 15:369\u2013378","journal-title":"Expert Opin Drug Deliv"},{"key":"2196_CR11","doi-asserted-by":"crossref","unstructured":"Bhushan B, Bhushan B, Baumann (2007) Springer handbook of nanotechnology vol 2. Springer","DOI":"10.1007\/978-3-540-29857-1"},{"key":"2196_CR12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/pharmaceutics11090473","volume":"11","author":"BA Bony","year":"2019","unstructured":"Bony BA, Kievit FM (2019) A role for nanoparticles in treating traumatic brain injury. Pharmaceutics 11:473","journal-title":"Pharmaceutics"},{"key":"2196_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","volume":"128","author":"V Bourganis","year":"2018","unstructured":"Bourganis V, Kammona O, Alexopoulos A, Kiparissides C (2018a) Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur J Pharm Biopharm 128:337\u2013362. https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.009","journal-title":"Eur J Pharm Biopharm"},{"key":"2196_CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","volume":"128","author":"V Bourganis","year":"2018","unstructured":"Bourganis V, Kammona O, Alexopoulos A, Kiparissides CJEJOP, biopharmaceutics (2018) Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics. Eur J Pharm Biopharm 128:337\u2013362","journal-title":"Eur J Pharm Biopharm"},{"key":"2196_CR15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"G Bozzuto","year":"2015","unstructured":"Bozzuto G, Molinari A (2015) Liposomes as nanomedical devices. Int J Nanomed 10:975","journal-title":"Int J Nanomed"},{"key":"2196_CR16","doi-asserted-by":"publisher","first-page":"a028241","DOI":"10.1101\/cshperspect.a028241","volume":"9","author":"XM Bustamante-Marin","year":"2017","unstructured":"Bustamante-Marin XM, Ostrowski LE (2017) Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol 9:a028241. https:\/\/doi.org\/10.1101\/cshperspect.a028241","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2196_CR17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/acs.molpharmaceut.9b00489","volume":"17","author":"C Cahalane","year":"2020","unstructured":"Cahalane C, Bonezzi J, Shelestak J, Clements R, Boika A, Yun YH, Shriver LP (2020) Targeted delivery of anti-inflammatory and imaging agents to microglial cells with polymeric nanoparticles. Mol Pharm 17:1816\u20131826","journal-title":"Mol Pharm"},{"key":"2196_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1773-2247(10)50001-7","volume":"20","author":"C Caramella","year":"2010","unstructured":"Caramella C, Ferrari F, Bonferoni M, Rossi S, Sandri G (2010) Chitosan and its derivatives as drug penetration enhancers. J Drug Deliv Sci Technol 20:5\u201313","journal-title":"J Drug Deliv Sci Technol"},{"key":"2196_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3389\/fimmu.2017.00970","volume":"8","author":"E Casals","year":"2017","unstructured":"Casals E, Gusta MF, Piella J, Casals G, Jim\u00e9nez W, Puntes V (2017) Intrinsic and extrinsic properties affecting innate immune responses to nanoparticles: the case of cerium oxide. Front Immunol 8:970. https:\/\/doi.org\/10.3389\/fimmu.2017.00970","journal-title":"Front Immunol"},{"key":"2196_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tips.2019.11.001","volume":"41","author":"M Charabati","year":"2020","unstructured":"Charabati M, Rabanel JM, Ramassamy C, Prat A (2020) Overcoming the brain barriers: from immune cells to nanoparticles. Trends Pharmacol Sci 41:42\u201354. https:\/\/doi.org\/10.1016\/j.tips.2019.11.001","journal-title":"Trends Pharmacol Sci"},{"key":"2196_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4103\/2231-4040.90876","volume":"2","author":"M Chaturvedi","year":"2011","unstructured":"Chaturvedi M, Kumar M, Pathak K (2011) A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res 2:215\u2013222. https:\/\/doi.org\/10.4103\/2231-4040.90876","journal-title":"J Adv Pharm Technol Res"},{"key":"2196_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen H, Yang GZX, Getachew H, Acosta C, S\u00e1nchez CS, Konofagou EE (2016) Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor. Sci Rep 6:1\u20138","journal-title":"Sci Rep"},{"key":"2196_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1039\/c7bm00886d","volume":"6","author":"HH Chowdhury","year":"2018","unstructured":"Chowdhury HH, Cerqueira SR, Sousa N, Oliveira JM, Reis RL, Zorec R (2018) The uptake, retention and clearance of drug-loaded dendrimer nanoparticles in astrocytes - electrophysiological quantification. Biomater Sci 6:388\u2013397. https:\/\/doi.org\/10.1039\/c7bm00886d","journal-title":"Biomater Sci"},{"key":"2196_CR24","doi-asserted-by":"publisher","unstructured":"Chung EP, Cotter JD, Prakapenka AV, Cook RL, DiPerna DM, Sirianni RW (2020) Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles. Pharmaceutics 12. https:\/\/doi.org\/10.3390\/pharmaceutics12020093","DOI":"10.3390\/pharmaceutics12020093"},{"key":"2196_CR25","doi-asserted-by":"crossref","unstructured":"Colton CA, Wilcock DM (2010) Assessing activation states in microglia. CNS Neurol Disord-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 9:174\u2013191","DOI":"10.2174\/187152710791012053"},{"key":"2196_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","volume":"295","author":"C Costa","year":"2019","unstructured":"Costa C, Moreira J, Amaral M, Lobo JS, Silva ACJJOCR (2019) Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. J Control Release 295:187\u2013200","journal-title":"J Control Release"},{"key":"2196_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","volume":"11","author":"CP Costa","year":"2021","unstructured":"Costa CP, Moreira JN, Sousa Lobo JM, Silva AC (2021) Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in vivo studies. Acta Pharmaceutica Sinica B 11:925\u2013940. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.012","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2196_CR28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2217\/nnm.10.89","volume":"5","author":"H Dai","year":"2010","unstructured":"Dai H et al (2010) Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine 5:1317\u20131329","journal-title":"Nanomedicine"},{"key":"2196_CR29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505\u2013522","journal-title":"J Control Release"},{"key":"2196_CR30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/21691401.2014.953633","volume":"44","author":"H Daraee","year":"2016","unstructured":"Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A (2016) Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol 44:381\u2013391","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2196_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/ijn.s596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3:133\u2013149. https:\/\/doi.org\/10.2147\/ijn.s596","journal-title":"Int J Nanomedicine"},{"key":"2196_CR32","doi-asserted-by":"publisher","first-page":"e1800917","DOI":"10.1002\/marc.201800917","volume":"40","author":"N Deirram","year":"2019","unstructured":"Deirram N, Zhang C, Kermaniyan SS, Johnston APR, Such GK (2019) pH-responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun 40:e1800917. https:\/\/doi.org\/10.1002\/marc.201800917","journal-title":"Macromol Rapid Commun"},{"key":"2196_CR33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/jpet.108.145565","volume":"328","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH (2009) Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. J Pharmacol Exp Ther 328:312\u2013320","journal-title":"J Pharmacol Exp Ther"},{"key":"2196_CR34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/08942680152007936","volume":"14","author":"M Durand","year":"2001","unstructured":"Durand M et al (2001) Preliminary study of the deposition of aerosol in the maxillary sinuses using a plastinated model. J Aerosol Med 14:83\u201393","journal-title":"J Aerosol Med"},{"key":"2196_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","volume":"49","author":"EM Elmowafy","year":"2019","unstructured":"Elmowafy EM, Tiboni M, Soliman ME (2019) Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig 49:347\u2013380. https:\/\/doi.org\/10.1007\/s40005-019-00439-x","journal-title":"J Pharm Investig"},{"key":"2196_CR36","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/jps.24557","volume":"104","author":"YSR Elnaggar","year":"2015","unstructured":"Elnaggar YSR, Etman SM, Abdelmonsif DA, Abdallah OY (2015) Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: optimization, biological efficacy, and potential toxicity. J Pharm Sci 104:3544\u20133556. https:\/\/doi.org\/10.1002\/jps.24557","journal-title":"J Pharm Sci"},{"key":"2196_CR37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinthera.2015.03.001","volume":"37","author":"C English","year":"2015","unstructured":"English C, Aloi JJ (2015) New FDA-approved disease-modifying therapies for multiple sclerosis. Clin Ther 37:691\u2013715","journal-title":"Clin Ther"},{"key":"2196_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","volume":"143","author":"F Erd\u0151","year":"2018","unstructured":"Erd\u0151 F, Bors LA, Farkas D, Bajza \u00c1, Gizurarson S (2018) Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull 143:155\u2013170. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.10.009","journal-title":"Brain Res Bull"},{"key":"2196_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/ijn.S15881","volume":"6","author":"S Eskandari","year":"2011","unstructured":"Eskandari S, Varshosaz J, Minaiyan M, Tabbakhian M (2011) Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Nanomedicine 6:363\u2013371. https:\/\/doi.org\/10.2147\/ijn.S15881","journal-title":"Int J Nanomedicine"},{"key":"2196_CR40","doi-asserted-by":"crossref","unstructured":"Fan Y, Chen M, Zhang J, Maincent P, Xia X, Wu W (2018) Updated progress of nanocarrier-based intranasal drug delivery systems for treatment of brain diseases. Crit Rev\u2122 Therapeut Drug Carrier Syst 35","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018024697"},{"key":"2196_CR41","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1039\/c9bm00931k","volume":"7","author":"G Farahavar","year":"2019","unstructured":"Farahavar G, Abolmaali SS, Gholijani N, Nejatollahi F (2019) Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools. Biomater Sci 7:4000\u20134016. https:\/\/doi.org\/10.1039\/c9bm00931k","journal-title":"Biomater Sci"},{"key":"2196_CR42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/B:NEUR.0000010089.37032.48","volume":"32","author":"P Field","year":"2003","unstructured":"Field P, Li Y, Raisman GJJON (2003) Ensheathment of the olfactory nerves in the adult rat. J Neurocytol 32:317\u2013324","journal-title":"J Neurocytol"},{"key":"2196_CR43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/pharmaceutics13020201","volume":"13","author":"A Froelich","year":"2021","unstructured":"Froelich A, Osma\u0142ek T, Jadach B, Puri V, Michniak-Kohn B (2021) Microemulsion-based media in nose-to-brain drug delivery. Pharmaceutics 13:201","journal-title":"Pharmaceutics"},{"key":"2196_CR44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1248\/bpb.30.1007","volume":"30","author":"T Furubayashi","year":"2007","unstructured":"Furubayashi T et al (2007) Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs. Biol Pharm Bull 30:1007\u20131010. https:\/\/doi.org\/10.1248\/bpb.30.1007","journal-title":"Biol Pharm Bull"},{"key":"2196_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","volume":"10","author":"S G\u00e4nger","year":"2018","unstructured":"G\u00e4nger S, Schindowski K (2018) Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics 10:116. https:\/\/doi.org\/10.3390\/pharmaceutics10030116","journal-title":"Pharmaceutics"},{"key":"2196_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40005-020-00482-z","volume":"50","author":"M Gao","year":"2020","unstructured":"Gao M, Shen X, Mao S (2020) Factors influencing drug deposition in thenasal cavity upon delivery via nasal sprays. J Pharm Investig 50:251\u2013259. https:\/\/doi.org\/10.1007\/s40005-020-00482-z","journal-title":"J Pharm Investig"},{"key":"2196_CR47","first-page":"751","volume":"11","author":"HE Gendelman","year":"2015","unstructured":"Gendelman HE et al (2015) Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine: Nanotechnology. Biol Med 11:751\u2013767","journal-title":"Biol Med"},{"issue":"3","key":"2196_CR48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","volume":"11","author":"M Ghadiri","year":"2019","unstructured":"Ghadiri M, Young PM, Traini DJP (2019) Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes. Pharmaceutics 11(3):113","journal-title":"Pharmaceutics"},{"key":"2196_CR49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41582-019-0227-8","volume":"15","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Deuschl G (2019) Neuroinflammation\u2014a common thread in neurological disorders. Nat Rev Neurol 15:429\u2013430","journal-title":"Nat Rev Neurol"},{"key":"2196_CR50","doi-asserted-by":"crossref","unstructured":"Gitler AD, Dhillon P, Shorter J (2017) Neurodegenerative disease: models, mechanisms, and a new hope. The Company of Biologists Ltd","DOI":"10.1242\/dmm.030205"},{"key":"2196_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0169-409X(93)90015-V","volume":"11","author":"S Gizurarson","year":"1993","unstructured":"Gizurarson S (1993) The relevance of nasal physiology to the design of drug absorption studies. Adv Drug Deliv Rev 11:329\u2013347. https:\/\/doi.org\/10.1016\/0169-409X(93)90015-V","journal-title":"Adv Drug Deliv Rev"},{"key":"2196_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jconrel.2020.11.019","volume":"331","author":"LF Gonz\u00e1lez","year":"2021","unstructured":"Gonz\u00e1lez LF, Acu\u00f1a E, Arellano G, Morales P, Sotomayor P, Oyarzun-Ampuero F, Naves R (2021) Intranasal delivery of interferon-\u03b2-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: a promising simple, effective, non-invasive, and low-cost therapy. J Control Release 331:443\u2013459. https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.019","journal-title":"J Control Release"},{"key":"2196_CR53","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1023\/A:1025053115583","volume":"20","author":"CL Graff","year":"2003","unstructured":"Graff CL, Pollack GM (2003) P-Glycoprotein attenuates brain uptake of substrates after nasal instillation. Pharm Res 20:1225\u20131230","journal-title":"Pharm Res"},{"key":"2196_CR54","doi-asserted-by":"crossref","unstructured":"Greish K (2010) Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. In: Cancer nanotechnology. Springer, pp 25\u201337","DOI":"10.1007\/978-1-60761-609-2_3"},{"key":"2196_CR55","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.2147\/IJN.S116902","volume":"11","author":"J Guo","year":"2016","unstructured":"Guo J, Jiang X, Gui S (2016) RNA interference-based nanosystems for inflammatory bowel disease therapy. Int J Nanomed 11:5287","journal-title":"Int J Nanomed"},{"key":"2196_CR56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cocis.2008.01.005","volume":"13","author":"J Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez J, Gonz\u00e1lez C, Maestro A, Sol\u00e8 I, Pey C, Nolla J (2008) Nano-emulsions: new applications and optimization of their preparation. Curr Opin Colloid Interface Sci 13:245\u2013251","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"2196_CR57","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10:1008","journal-title":"Front Pharmacol"},{"key":"2196_CR58","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2174\/1567201816666190619122456","volume":"16","author":"H Han","year":"2019","unstructured":"Han H et al (2019) Monocytes as carriers of magnetic nanoparticles for tracking inflammation in the epileptic rat brain. Curr Drug Deliv 16:637\u2013644. https:\/\/doi.org\/10.2174\/1567201816666190619122456","journal-title":"Curr Drug Deliv"},{"key":"2196_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12035-017-0728-7","volume":"55","author":"S Hernando","year":"2018","unstructured":"Hernando S, Herran E, Figueiro-Silva J, Pedraz JL, Igartua M, Carro E, Hernandez RM (2018) Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson\u2019s disease. Mol Neurobiol 55:145\u2013155. https:\/\/doi.org\/10.1007\/s12035-017-0728-7","journal-title":"Mol Neurobiol"},{"key":"2196_CR60","doi-asserted-by":"publisher","unstructured":"Hoyos-Ceballos GP et al (2020) PLGA-PEG-ANG-2 nanoparticles for blood-brain barrier crossing: proof-of-concept study. Pharmaceutics 12. https:\/\/doi.org\/10.3390\/pharmaceutics12010072","DOI":"10.3390\/pharmaceutics12010072"},{"key":"2196_CR61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10863-018-9780-x","volume":"51","author":"C Huart","year":"2019","unstructured":"Huart C, Rombaux P, Hummel TJJOB, biomembranes, (2019) Neural plasticity in developing and adult olfactory pathways\u2013focus on the human olfactory bulb. J Bioenerg Biomembr 51:77\u201387","journal-title":"J Bioenerg Biomembr"},{"key":"2196_CR62","doi-asserted-by":"publisher","unstructured":"Ibrahim Bekraki A (2020) Chapter 7 - Liposomes-and niosomes-based drug delivery systems for tuberculosis treatment. In: Kesharwani P (ed) Nanotechnology based approaches for tuberculosis treatment. Academic Press, pp 107\u2013122. https:\/\/doi.org\/10.1016\/B978-0-12-819811-7.00007-2","DOI":"10.1016\/B978-0-12-819811-7.00007-2"},{"key":"2196_CR63","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/molecules25081929","volume":"25","author":"SU Islam","year":"2020","unstructured":"Islam SU, Shehzad A, Ahmed MB, Lee YS (2020) Intranasal delivery of nanoformulations: a potential way of treatment for neurological disorders. Molecules 25:1929","journal-title":"Molecules"},{"key":"2196_CR64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2017.08.006","volume":"108","author":"SJ Jeong","year":"2017","unstructured":"Jeong SJ et al (2017a) Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice. Neurobiol Dis 108:73\u201382","journal-title":"Neurobiol Dis"},{"key":"2196_CR65","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","volume":"7","author":"NJ Johnson","year":"2010","unstructured":"Johnson NJ, Hanson LR, Frey WHJMP (2010) Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm 7:884\u2013893","journal-title":"Mol Pharm"},{"key":"2196_CR66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1158\/1078-0432.Ccr-19-1834","volume":"26","author":"R Juthani","year":"2020","unstructured":"Juthani R et al (2020) Ultrasmall core-shell silica nanoparticles for precision drug delivery in a high-grade malignant brain tumor model. Clin Cancer Res 26:147\u2013158. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-1834","journal-title":"Clin Cancer Res"},{"key":"2196_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1517\/17425247.5.1.119","volume":"5","author":"HY Karasulu","year":"2008","unstructured":"Karasulu HY (2008) Microemulsions as novel drug carriers: the formation, stability, applications and toxicity. Expert Opin Drug Deliv 5:119\u2013135. https:\/\/doi.org\/10.1517\/17425247.5.1.119","journal-title":"Expert Opin Drug Deliv"},{"key":"2196_CR68","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/acschemneuro.0c00427","volume":"11","author":"N Kaur","year":"2020","unstructured":"Kaur N, Chugh H, Sakharkar MK, Dhawan U, Chidambaram SB, Chandra R (2020) Neuroinflammation mechanisms and phytotherapeutic intervention: a systematic review. ACS Chem Neurosci 11:3707\u20133731","journal-title":"ACS Chem Neurosci"},{"key":"2196_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00891-5","author":"L-A Keller","year":"2021","unstructured":"Keller L-A, Merkel O, Popp A (2021) Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-020-00891-5","journal-title":"Drug Deliv Transl Res"},{"key":"2196_CR70","doi-asserted-by":"crossref","unstructured":"Keller L-A, Merkel O, Popp AJDD, Research T (2021b) Intranasal drug delivery: opportunities and toxicologic challenges during drug development.1\u201323","DOI":"10.1007\/s13346-020-00891-5"},{"key":"2196_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","volume":"30","author":"RA Khallaf","year":"2020","unstructured":"Khallaf RA, Aboud HM, Sayed OM (2020) Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res 30:163\u2013173. https:\/\/doi.org\/10.1080\/08982104.2019.1610435","journal-title":"J Liposome Res"},{"key":"2196_CR72","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","volume":"9","author":"M Khongkow","year":"2019","unstructured":"Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D, Namdee K (2019) Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration. Sci Rep 9:8278. https:\/\/doi.org\/10.1038\/s41598-019-44569-6","journal-title":"Sci Rep"},{"key":"2196_CR73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2014.01.001","volume":"258","author":"KA Kigerl","year":"2014","unstructured":"Kigerl KA, de Rivero Vaccari JP, Dietrich WD, Popovich PG, Keane RW (2014) Pattern recognition receptors and central nervous system repair. Exp Neurol 258:5\u201316","journal-title":"Exp Neurol"},{"key":"2196_CR74","doi-asserted-by":"publisher","first-page":"e1802309","DOI":"10.1002\/adma.201802309","volume":"30","author":"D Kim","year":"2018","unstructured":"Kim D, Shin K, Kwon SG, Hyeon T (2018) Synthesis and biomedical applications of multifunctional nanoparticles. Adv Mater 30:e1802309. https:\/\/doi.org\/10.1002\/adma.201802309","journal-title":"Adv Mater"},{"key":"2196_CR75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1440-1843.2003.00493.x","volume":"8","author":"DA Knight","year":"2003","unstructured":"Knight DA, Holgate STJR (2003) The Airway Epithelium: Structural and Functional Properties in Health and Disease. Respirology 8:432\u2013446","journal-title":"Respirology"},{"key":"2196_CR76","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","volume":"25","author":"J Koenigsknecht-Talboo","year":"2005","unstructured":"Koenigsknecht-Talboo J, Landreth GE (2005) Microglial phagocytosis induced by fibrillar \u03b2-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25:8240\u20138249","journal-title":"J Neurosci"},{"key":"2196_CR77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","volume":"189","author":"L Kozlovskaya","year":"2014","unstructured":"Kozlovskaya L, Abou-Kaoud M, Stepensky DJJOCR (2014) Quantitative analysis of drug delivery to the brain via nasal route. J Control Release 189:133\u2013140","journal-title":"J Control Release"},{"key":"2196_CR78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2\u201314","journal-title":"Adv Drug Deliv Rev"},{"key":"2196_CR79","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/nnm.10.131","volume":"6","author":"SA Kulkarni","year":"2011","unstructured":"Kulkarni SA, Feng SS (2011) Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier. Nanomedicine (Lond) 6:377\u2013394. https:\/\/doi.org\/10.2217\/nnm.10.131","journal-title":"Nanomedicine (Lond)"},{"key":"2196_CR80","doi-asserted-by":"crossref","unstructured":"Kumar A, Pandey AN, Jain SKJDd (2016a) Nasal-nanotechnology: revolution for efficient therapeutics delivery. 23:671\u2013683","DOI":"10.3109\/10717544.2014.920431"},{"key":"2196_CR81","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/2211738505666170515113936","volume":"5","author":"H Kumar","year":"2017","unstructured":"Kumar H, Mishra G, Sharma AK, Gothwal A, Kesharwani P, Gupta U (2017) Intranasal drug delivery: a non-invasive approach for the better delivery of neurotherapeutics. Pharm Nanotechnol 5:203\u2013214. https:\/\/doi.org\/10.2174\/2211738505666170515113936","journal-title":"Pharm Nanotechnol"},{"key":"2196_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","volume":"358","author":"M Kumar","year":"2008","unstructured":"Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K (2008a) Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 358:285\u2013291. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.03.029","journal-title":"Int J Pharm"},{"key":"2196_CR83","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/10611860802476504","volume":"16","author":"M Kumar","year":"2008","unstructured":"Kumar M, Misra A, Mishra AK, Mishra P, Pathak K (2008b) Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J Drug Target 16:806\u2013814. https:\/\/doi.org\/10.1080\/10611860802476504","journal-title":"J Drug Target"},{"key":"2196_CR84","doi-asserted-by":"publisher","unstructured":"Kumar M, Sharma P, Maheshwari R, Tekade M, Shrivastava SK, Tekade RK (2018) Chapter 15 - Beyond the blood\u2013brain barrier: facing new challenges and prospects of nanotechnology-mediated targeted delivery to the brain. In: Kesharwani P, Gupta U (eds) Nanotechnology-based targeted drug delivery systems for brain tumors. Academic Press, pp 397\u2013437. https:\/\/doi.org\/10.1016\/B978-0-12-812218-1.00015-4","DOI":"10.1016\/B978-0-12-812218-1.00015-4"},{"key":"2196_CR85","doi-asserted-by":"crossref","unstructured":"Kumar NN, Gautam M, Lochhead JJ, Wolak DJ, Ithapu V, Singh V, Thorne RGJSR (2016b) Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. 6:1-14","DOI":"10.1038\/srep31732"},{"key":"2196_CR86","doi-asserted-by":"crossref","unstructured":"Kumar R, Aadil KR, Ranjan S, Kumar VB (2020) Advances in nanotechnology and nanomaterials based strategies for neural tissue engineering. J Drug Deliv Sci Technol 57:101617","DOI":"10.1016\/j.jddst.2020.101617"},{"key":"2196_CR87","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molmed.2016.12.010","volume":"23","author":"J Lavoie","year":"2017","unstructured":"Lavoie J et al (2017) The Olfactory Neural Epithelium as a Tool in Neuroscience. Trends Mol Med 23:100\u2013103","journal-title":"Trends Mol Med"},{"key":"2196_CR88","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.neuropharm.2008.10.016","volume":"56","author":"Y Li","year":"2009","unstructured":"Li Y, Hu X, Liu Y, Bao Y, An L (2009) Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 56:580\u2013589. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.10.016","journal-title":"Neuropharmacology"},{"key":"2196_CR89","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487","journal-title":"Nature"},{"key":"2196_CR90","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614\u2013628","journal-title":"Adv Drug Deliv Rev"},{"key":"2196_CR91","doi-asserted-by":"crossref","unstructured":"Lochhead JJ, Thorne RG (2014) Intranasal drug delivery to the brain. In: Drug delivery to the brain. Springer, pp 401\u2013431","DOI":"10.1007\/978-1-4614-9105-7_14"},{"key":"2196_CR92","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","volume":"1153","author":"RB Maccioni","year":"2009","unstructured":"Maccioni RB, Rojo LE, Fernandez JA, Kuljis RO (2009) The role of neuroimmunomodulation in Alzheimer\u2019s disease. Ann N Y Acad Sci 1153:240\u2013246","journal-title":"Ann N Y Acad Sci"},{"key":"2196_CR93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","volume":"6","author":"K Madaan","year":"2014","unstructured":"Madaan K, Kumar S, Poonia N, Lather V, Pandita D (2014) Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci 6:139","journal-title":"J Pharm Bioallied Sci"},{"key":"2196_CR94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","volume":"30","author":"Y Malam","year":"2009","unstructured":"Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592\u2013599","journal-title":"Trends Pharmacol Sci"},{"key":"2196_CR95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","volume":"29","author":"E Marttin","year":"1998","unstructured":"Marttin E, Schipper NG, Verhoef JC, Merkus FWJA (1998) Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev 29:13\u201338","journal-title":"Adv Drug Deliv Rev"},{"key":"2196_CR96","doi-asserted-by":"crossref","unstructured":"Masserini M (2013) Nanoparticles for brain drug delivery. Int Scholar Res Notices 2013","DOI":"10.1155\/2013\/238428"},{"key":"2196_CR97","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0197-4580(01)00307-4","volume":"22","author":"L Meda","year":"2001","unstructured":"Meda L, Baron P, Scarlato G (2001) Glial activation in Alzheimer\u2019s disease: the role of A\u03b2 and its associated proteins. Neurobiol Aging 22:885\u2013893","journal-title":"Neurobiol Aging"},{"key":"2196_CR98","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/ijn.S151474","volume":"13","author":"Q Meng","year":"2018","unstructured":"Meng Q et al (2018) Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease. Int J Nanomedicine 13:705\u2013718. https:\/\/doi.org\/10.2147\/ijn.S151474","journal-title":"Int J Nanomedicine"},{"key":"2196_CR99","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/nn404872e","volume":"8","author":"MK Mishra","year":"2014","unstructured":"Mishra MK et al (2014) Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano 8:2134\u20132147","journal-title":"ACS Nano"},{"key":"2196_CR100","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379:146\u2013157. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.06.019","journal-title":"Int J Pharm"},{"key":"2196_CR101","doi-asserted-by":"crossref","unstructured":"Moeinzadeh S, Jabbari E (2017) Nanoparticles and their applications. In: Springer handbook of nanotechnology. Springer, pp 335\u2013361","DOI":"10.1007\/978-3-662-54357-3_11"},{"key":"2196_CR102","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, M\u00e4der K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art. Eur J Pharm Biopharm 50:161\u2013177","journal-title":"Eur J Pharm Biopharm"},{"key":"2196_CR103","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejpb.2018.11.002","volume":"133","author":"T Musumeci","year":"2018","unstructured":"Musumeci T et al (2018) Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents. Eur J Pharm Biopharm 133:309\u2013320. https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.002","journal-title":"Eur J Pharm Biopharm"},{"key":"2196_CR104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3329\/ijpls.v2i3.15457","volume":"2","author":"B Neha","year":"2013","unstructured":"Neha B, Ganesh B, Preeti K (2013) Drug delivery to the brain using polymeric nanoparticles: a review. Int J Pharmaceut Life Sci 2:107\u2013132","journal-title":"Int J Pharmaceut Life Sci"},{"key":"2196_CR105","doi-asserted-by":"crossref","unstructured":"Newman SP, Pitcairn GR, Dalby RN (2004) Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit Rev\u2122 Therapeut Drug Carrier Syst 21","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i1.20"},{"key":"2196_CR106","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/1389200217666160406120509","volume":"17","author":"P Oliveira","year":"2016","unstructured":"Oliveira P, Fortuna A, Alves G, Falcao A (2016) Drug-metabolizing enzymes and efflux transporters in nasal epithelium: influence on the bioavailability of intranasally administered drugs. Curr Drug Metab 17:628\u2013647","journal-title":"Curr Drug Metab"},{"key":"2196_CR107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2015.10.015","volume":"75","author":"S Papa","year":"2016","unstructured":"Papa S et al (2016) Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury. Biomaterials 75:13\u201324","journal-title":"Biomaterials"},{"key":"2196_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16:1\u201333","journal-title":"J Nanobiotechnol"},{"key":"2196_CR109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2019.04.012","volume":"209","author":"M Peviani","year":"2019","unstructured":"Peviani M, Palmiero UC, Cecere F, Milazzo R, Moscatelli D, Biffi A (2019) Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release. Biomaterials 209:25\u201340","journal-title":"Biomaterials"},{"key":"2196_CR110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","volume":"109","author":"R Raj","year":"2018","unstructured":"Raj R, Wairkar S, Sridhar V, Gaud R (2018) Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity. Int J Biol Macromol 109:27\u201335. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.12.056","journal-title":"Int J Biol Macromol"},{"key":"2196_CR111","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353:777\u2013783","journal-title":"Science"},{"key":"2196_CR112","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jddst.2015.05.002","volume":"32","author":"G Rassu","year":"2016","unstructured":"Rassu G, Soddu E, Cossu M, Gavini E, Giunchedi P, Dalpiaz A (2016) Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review. J Drug Deliv Sci Technol 32:77\u201387","journal-title":"J Drug Deliv Sci Technol"},{"key":"2196_CR113","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2018.12.007","volume":"294","author":"F Rinaldi","year":"2019","unstructured":"Rinaldi F et al (2019) inPentasomes: an innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice. J Control Release 294:17\u201326","journal-title":"J Control Release"},{"key":"2196_CR114","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s11051-011-0275-5","volume":"13","author":"MC Roco","year":"2011","unstructured":"Roco MC, Mirkin CA, Hersam MC (2011) Nanotechnology research directions for societal needs in 2020: summary of international study. J Nanopart Res 13:897\u2013919. https:\/\/doi.org\/10.1007\/s11051-011-0275-5","journal-title":"J Nanopart Res"},{"key":"2196_CR115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.drudis.2019.10.005","volume":"25","author":"F Sabir","year":"2020","unstructured":"Sabir F, Ismail R, Csoka IJD (2020) Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook. Drug Discov Today 25:185\u2013194","journal-title":"Drug Discov Today"},{"key":"2196_CR116","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1039\/c9tb02700a","volume":"8","author":"S Saha","year":"2020","unstructured":"Saha S et al (2020) Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma. J Mater Chem B 8:4318\u20134330. https:\/\/doi.org\/10.1039\/c9tb02700a","journal-title":"J Mater Chem B"},{"key":"2196_CR117","doi-asserted-by":"crossref","unstructured":"Schipper NG, Verhoef JC, Merkus FWJPr (1991) The nasal mucociliary clearance: relevance to nasal drug delivery. 8:807-814","DOI":"10.1023\/A:1015830907632"},{"key":"2196_CR118","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","volume":"7","author":"U Seju","year":"2011","unstructured":"Seju U, Kumar A, Sawant KK (2011) Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater 7:4169\u20134176. https:\/\/doi.org\/10.1016\/j.actbio.2011.07.025","journal-title":"Acta Biomater"},{"key":"2196_CR119","first-page":"2088","volume":"46","author":"K Selvaraj","year":"2018","unstructured":"Selvaraj K, Gowthamarajan K, Karri VVSR (2018) Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomed Biotechnol 46:2088\u20132095","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2196_CR120","doi-asserted-by":"crossref","unstructured":"Selvaraj K, Gowthamarajan K, Karri VVSRJAc, nanomedicine, biotechnology (2018b) Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. 46:2088-2095","DOI":"10.1080\/21691401.2017.1420073"},{"key":"2196_CR121","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G (2017) Neuroinflammation pathways: a general review. Int J Neurosci 127:624\u2013633","journal-title":"Int J Neurosci"},{"key":"2196_CR122","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijbiomac.2016.04.076","volume":"89","author":"B Shah","year":"2016","unstructured":"Shah B, Khunt D, Misra M, Padh H (2016) Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route*. Int J Biol Macromol 89:206\u2013218. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.04.076","journal-title":"Int J Biol Macromol"},{"key":"2196_CR123","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejphar.2015.08.046","volume":"765","author":"Y Shao","year":"2015","unstructured":"Shao Y, Peng H, Huang Q, Kong J, Xu H (2015) Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL\/6 mouse following cuprizone exposure for one week. Eur J Pharmacol 765:249\u2013257. https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.046","journal-title":"Eur J Pharmacol"},{"key":"2196_CR124","doi-asserted-by":"crossref","unstructured":"Shastri A, Bonifati DM, Kishore U (2013) Innate immunity and neuroinflammation. Mediators Inflamm 2013","DOI":"10.1155\/2013\/342931"},{"key":"2196_CR125","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1007\/s12035-016-0297-1","volume":"54","author":"M Sochocka","year":"2017","unstructured":"Sochocka M, Diniz BS, Leszek J (2017) Inflammatory response in the CNS: friend or foe? Mol Neurobiol 54:8071\u20138089","journal-title":"Mol Neurobiol"},{"key":"2196_CR126","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3389\/fphar.2020.01165","volume":"11","author":"Y Su","year":"2020","unstructured":"Su Y et al (2020) Intranasal delivery of targeted nanoparticles loaded with mir-132 to brain for the treatment of neurodegenerative diseases. Front Pharmacol 11:1165","journal-title":"Front Pharmacol"},{"key":"2196_CR127","doi-asserted-by":"crossref","unstructured":"Thorne R, Pronk G, Padmanabhan V, Frey Ii WJN (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. 127:481-496","DOI":"10.1016\/j.neuroscience.2004.05.029"},{"key":"2196_CR128","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/jnr.21325","volume":"85","author":"S Tilleux","year":"2007","unstructured":"Tilleux S, Hermans E (2007) Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85:2059\u20132070","journal-title":"J Neurosci Res"},{"key":"2196_CR129","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.medidd.2020.100027","volume":"7","author":"A Tiwari","year":"2020","unstructured":"Tiwari A, Mahadik KR, Gabhe SY (2020) Piperine: a comprehensive review of methods of isolation, purification, and biological properties. Med Drug Discov 7:100027. https:\/\/doi.org\/10.1016\/j.medidd.2020.100027","journal-title":"Med Drug Discov"},{"key":"2196_CR130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/biom10040642","volume":"10","author":"DA Tomalia","year":"2020","unstructured":"Tomalia DA, Nixon LS, Hedstrand DM (2020) The role of branch cell symmetry and other critical nanoscale design parameters in the determination of dendrimer encapsulation properties. Biomolecules 10:642","journal-title":"Biomolecules"},{"key":"2196_CR131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","volume":"24","author":"VP Torchilin","year":"2007","unstructured":"Torchilin VP (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24:1\u201316","journal-title":"Pharm Res"},{"key":"2196_CR132","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejpb.2018.02.010","volume":"127","author":"V Trotta","year":"2018","unstructured":"Trotta V et al (2018) Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Eur J Pharm Biopharm 127:250\u2013259. https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.010","journal-title":"Eur J Pharm Biopharm"},{"key":"2196_CR133","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4155\/tde.13.38","volume":"4","author":"SY Tzeng","year":"2013","unstructured":"Tzeng SY, Green JJ (2013) Therapeutic nanomedicine for brain cancer. Ther Deliv 4:687\u2013704","journal-title":"Ther Deliv"},{"key":"2196_CR134","doi-asserted-by":"crossref","unstructured":"Ud Din F, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomed 12:7291","DOI":"10.2147\/IJN.S146315"},{"key":"2196_CR135","first-page":"1","volume":"10","author":"MC Veronesi","year":"2020","unstructured":"Veronesi MC, Alhamami M, Miedema SB, Yun Y, Ruiz-Cardozo M, Vannier MW (2020) Imaging of intranasal drug delivery to the brain. Am J Nucl Med Mol Imaging 10:1","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2196_CR136","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10611860500246217","volume":"13","author":"TK Vyas","year":"2005","unstructured":"Vyas TK, Babbar AK, Sharma RK, Misra A (2005) Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. J Drug Target 13:317\u2013324. https:\/\/doi.org\/10.1080\/10611860500246217","journal-title":"J Drug Target"},{"key":"2196_CR137","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jps.20480","volume":"95","author":"TK Vyas","year":"2006","unstructured":"Vyas TK, Babbar AK, Sharma RK, Singh S, Misra A (2006a) Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. J Pharm Sci 95:570\u2013580. https:\/\/doi.org\/10.1002\/jps.20480","journal-title":"J Pharm Sci"},{"key":"2196_CR138","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1208\/pt070108","volume":"7","author":"TK Vyas","year":"2006","unstructured":"Vyas TK, Babbar AK, Sharma RK, Singh S, Misra A (2006b) Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan. AAPS PharmSciTech 7:E49-e57. https:\/\/doi.org\/10.1208\/pt070108","journal-title":"AAPS PharmSciTech"},{"key":"2196_CR139","doi-asserted-by":"crossref","unstructured":"Wang K et al. (2020) Therapeutic nanomaterials for neurological diseases and cancer therapy. J Nanomater 2020","DOI":"10.1155\/2020\/2047379"},{"key":"2196_CR140","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","volume":"151","author":"Z Wen","year":"2011","unstructured":"Wen Z et al (2011) Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson\u2019s disease following intranasal administration. J Control Release 151:131\u2013138. https:\/\/doi.org\/10.1016\/j.jconrel.2011.02.022","journal-title":"J Control Release"},{"key":"2196_CR141","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00418-008-0410-2","volume":"130","author":"H Wolburg","year":"2008","unstructured":"Wolburg H, Wolburg-Buchholz K, Sam H, Horv\u00e1t S, Deli MA, Mack AF (2008) Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat. Histochem Cell Biol 130:127\u2013140","journal-title":"Histochem Cell Biol"},{"key":"2196_CR142","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","volume":"12","author":"S Yadav","year":"2016","unstructured":"Yadav S, Gandham SK, Panicucci R, Amiji MM (2016) Intranasal brain delivery of cationic nanoemulsion-encapsulated TNF\u03b1 siRNA in prevention of experimental neuroinflammation. Nanomedicine 12:987\u20131002. https:\/\/doi.org\/10.1016\/j.nano.2015.12.374","journal-title":"Nanomedicine"},{"key":"2196_CR143","doi-asserted-by":"publisher","first-page":"37885","DOI":"10.1021\/acsami.0c10500","volume":"12","author":"M Yao","year":"2020","unstructured":"Yao M et al (2020) Engineering of SPECT\/photoacoustic imaging\/antioxidative stress triple-function nanoprobe for advanced mesenchymal stem cell therapy of cerebral ischemia. ACS Appl Mater Interfaces 12:37885\u201337895. https:\/\/doi.org\/10.1021\/acsami.0c10500","journal-title":"ACS Appl Mater Interfaces"},{"key":"2196_CR144","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","volume":"6","author":"L Yildirimer","year":"2011","unstructured":"Yildirimer L, Thanh NTK, Loizidou M, Seifalian AM (2011) Toxicology and clinical potential of nanoparticles. Nano Today 6:585\u2013607. https:\/\/doi.org\/10.1016\/j.nantod.2011.10.001","journal-title":"Nano Today"},{"key":"2196_CR145","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijpharm.2013.11.049","volume":"461","author":"C Zhang","year":"2014","unstructured":"Zhang C et al (2014) Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer\u2019s disease. Int J Pharm 461:192\u2013202. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.11.049","journal-title":"Int J Pharm"},{"key":"2196_CR146","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2015.12.013","volume":"240","author":"F Zhang","year":"2016","unstructured":"Zhang F, Lin Y-A, Kannan S, Kannan RM (2016a) Targeting specific cells in the brain with nanomedicines for CNS therapies. J Control Release 240:212\u2013226","journal-title":"J Control Release"},{"key":"2196_CR147","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijpharm.2004.01.039","volume":"275","author":"Q Zhang","year":"2004","unstructured":"Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z (2004) Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 275:85\u201396. https:\/\/doi.org\/10.1016\/j.ijpharm.2004.01.039","journal-title":"Int J Pharm"},{"key":"2196_CR148","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1039\/C5BM00383K","volume":"4","author":"T-T Zhang","year":"2016","unstructured":"Zhang T-T, Li W, Meng G, Wang P, Liao W (2016b) Strategies for transporting nanoparticles across the blood\u2013brain barrier. Biomater Sci 4:219\u2013229","journal-title":"Biomater Sci"},{"key":"2196_CR149","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A et al (2020) Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules 25:3731","journal-title":"Molecules"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-021-02196-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T03:08:20Z","timestamp":1642043300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-021-02196-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s00210-021-02196-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}